Related Experiment Video
Updated: Jan 4, 2026

An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing
Published on: May 23, 2018
Single-cell protein profiling in microchambers with barcoded beads
Lucas Armbrecht1, Rafael Sebastian Müller1, Jonas Nikoloff1
1Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland.
Abstract:
Single-cell profiling provides insights into cellular behaviour that macroscale cell cultures and bulk measurements cannot reveal. In the context of personalized cancer treatment, the profiling of individual tumour cells may lead to higher success rates for therapies by rapidly selecting the most efficacious drugs. Currently, genomic analysis at the single-cell level is available through highly sensitive sequencing approaches. However, the identification and quantification of intracellular or secreted proteins or metabolites remains challenging. Here, we introduce a microfluidic method that facilitates capture, automated data acquisition and the multiplexed quantification of proteins from individual cells. The microfluidic platform comprises 1026 chambers with a volume of 152 pL each, in which single cells and barcoded beads are co-immobilized. We demonstrated multiplexed single-cell protein quantification with three different mammalian cell lines, including two model breast cancer cell lines. We established on-chip immunoassays for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), galectin-3 (Gal-3) and galectin-3 binding protein (Gal-3bp) with detection limits as low as 7.0 × 104, 2.3 × 105 and 1.8 × 103 molecules per cell, respectively. The three investigated cell types had high cytosolic levels of GAPDH and could be clearly differentiated by their expression levels of Gal-3 and Gal-3bp, which are important factors that contribute to cancer metastasis. Because it employed commercially available barcoded beads for this study, our platform could be easily used for the single-cell protein profiling of several hundred different targets. Moreover, this versatile method is applicable to the analysis of bacteria, yeast and mammalian cells and nanometre-sized lipid vesicles.
Insights
This study introduces a microfluidic platform for multiplexed single-cell protein quantification, overcoming challenges in analyzing individual cell proteins. The method enables precise protein detection, aiding personalized cancer treatment and diverse biological analyses.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Single-cell profiling offers unique insights beyond bulk measurements.
- Personalized cancer therapy benefits from individual tumor cell analysis.
- Quantifying proteins at the single-cell level remains a significant challenge.
Purpose of the Study:
- To develop a microfluidic method for multiplexed single-cell protein quantification.
- To enable automated data acquisition and analysis of intracellular or secreted proteins.
- To advance personalized cancer treatment through rapid drug efficacy selection.
Main Methods:
- A microfluidic platform with 1026 chambers for co-immobilizing single cells and barcoded beads.
- Development of on-chip immunoassays for protein detection.
- Demonstration using three mammalian cell lines, including breast cancer models.
Main Results:
- Multiplexed quantification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), galectin-3 (Gal-3), and galectin-3 binding protein (Gal-3bp) in single cells.
- Achieved low detection limits for target proteins (e.g., 1.8 × 10^3 molecules/cell for Gal-3bp).
- Successfully differentiated cell types based on Gal-3 and Gal-3bp expression, relevant to metastasis.
Conclusions:
- The microfluidic platform facilitates sensitive, multiplexed single-cell protein profiling.
- The method is versatile, applicable to various cell types and lipid vesicles.
- Commercial barcoded beads allow for easy scaling to hundreds of targets for diverse applications.

